Therapy Areas: AIDS & HIV
Oxford BioDynamics announces opening of clinical testing facility in UK for prostate screening test
3 April 2024 - Biotechnology company Oxford BioDynamics, Plc (AIM: OBD) announced on Wednesday that clinical validation of its EpiSwitch Prostate Screening (PSE) test has been completed at its newly c...
Micron Biomedical names new scientific advisor to CEO
28 February 2024 - Micron Biomedical, a US-based life science company, announced on Tuesday that it has named global public health pioneer Dr Seth Berkley as scientific advisor to the CEO.In the new r...
China accepts GSK's Shingrix application for at-risk adults
6 February 2024 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) said on Tuesday that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted ...
Takeda's HyQvia approved for maintenance therapy in CIDP patients
29 January 2024 - Biopharmaceutical company Takeda (TSE:4502) (NYSE:TAK) announced on Monday that HyQvia [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] has been approved i...
Allurion's Gastric Balloon introduced at Somerset NHS Foundation Trust for pre-surgical weight loss
23 January 2024 - Allurion Technologies Inc (NYSE: ALUR), a company focussed on ending obesity, announced on Tuesday that Somerset NHS Foundation Trust (FT) has pioneers the use of the company's ...
Takeda's HYQVIA gains FDA approval for CIDP maintenance therapy
16 January 2024 - Biopharmaceutical company Takeda (TSE:4502) (NYSE:TAK) said on Tuesday that it has secured US Food and Drug Administration (FDA) approval for HYQVIA (Immune Globulin Infusion 10% [Hu...